HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Obesity-Related Genetic Determinants of Heart Failure Prognosis.

AbstractPURPOSE:
Recent advances in genomics offer a smart option for predicting future risk of disease and prognosis. The objective of this study was to examine the prognostic value in heart failure (HF) patients, of a series of single nucleotide polymorphisms (SNPs).
METHODS:
A selection of 192 SNPs found to be related with obesity, body mass index, circulating lipids or cardiovascular diseases were genotyped in 191 patients with HF. Anthropometrical and clinical variables were collected for each patient, and death and readmission by HF were registered as the primary endpoint.
RESULTS:
A total of 53 events were registered during a follow-up period of 438 (263-1077) days (median (IQR)). Eight SNPs strongly related to obesity and HF prognosis were selected as possible prognostic variables. From these, rs10189761 and rs737337 variants were independently associated with HF prognosis (HR 2.295 (1.287-4.089, 95% CI); p = 0.005), whereas rs10423928, rs1800437, rs737337 and rs9351814 were related with bad prognosis only in obese patients (HR 2.142 (1.438-3.192, 95% CI); p = 0.00018). Combined scores of the genomic variants were highly predictive of poor prognosis.
CONCLUSIONS:
SNPs rs10189761 and rs737337 were identified, for the first time, as independent predictors of major clinical outcomes in patients with HF. The data suggests an additive predictive value of these SNPs for a HF prognosis. In particular for obese patients, SNPs rs10423928, rs1800437, rs737337 and rs9351814 were related with a bad prognosis. Combined scores weighting the risk of each genomic variant could effect interesting new tools to stratify the prognostic risk of HF patients.
AuthorsR M Agra, M Gago-Dominguez, B Paradela-Dobarro, M Torres-Español, L Alvarez, A Fernandez-Trasancos, A Varela-Roman, M Calaza, S Eiras, E Alvarez, A Carracedo, J R Gonzalez-Juanatey
JournalCardiovascular drugs and therapy (Cardiovasc Drugs Ther) Vol. 33 Issue 4 Pg. 415-424 (08 2019) ISSN: 1573-7241 [Electronic] United States
PMID31209632 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Lipids
Topics
  • Aged
  • Aged, 80 and over
  • Biomarkers (blood)
  • Body Mass Index
  • Disease Progression
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Heart Failure (genetics, mortality, physiopathology)
  • Humans
  • Lipids (blood)
  • Male
  • Middle Aged
  • Obesity (genetics, mortality, physiopathology)
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: